Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2025 ∙ Hegazi, M. A. Sayed, M. H. Butt, N. S. Alahmadi, T. S. Zubairi, N. A. Elson, W. A.
Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis
Eastern Mediterranean Saudi Arabia Parents/caregivers COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Montroy, J. Yan, C. Khan, F. Forbes, N. Krishnan, R. Tunis, M. Salvadori, M. I.
Post-exposure prophylaxis for the prevention of measles: A systematic review
All age groups Measles Efficacy/effectiveness
Rating:
Low
2025 ∙ Pennisi, F. D'Amelio, A. C. Cuciniello, R. Borlini, S. Mirzaian, L. Ricciardi, G. E. Minerva, M. Gianfredi, V. Signorelli, C.
Post-Vaccination Anaphylaxis in Adults: A Systematic Review and Meta-Analysis
Adults Older adults Safety
Rating:
Critically low
2025 ∙ Abaate, T. J. Buowari, D. Y. Agiri, U. A. Inimgba, T. Ogbonna, V. I. Onyeaghala, C. Worgu, G. O. Somiari, A. Ezebuiro, E. I. Onuah, I. A.
Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis
Africa Nigeria Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Gaidhane, S. Padmapriya, G. Kaur, I. Lal, M. Iqbal, S. Prasad, G. V. S. Pramanik, A. Sharma, P. Malik, P. Vishwakarma, T. Punia, A. Jagga, M. Mehta, R. Sah, S. Shabil, M. Satapathy, P. Bushi, G. Parsa, A. D. Kabir, R.
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis
Adolescents Adults Mpox Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Askar, M. Ali, K. A. Batke, M. Brugger, T. Falman, A. Robertson, A. H. Perez, J. J. Johansen, K. de Jonge, J. Krause, T. G. Kulper-Schiek, W. Meerpohl, J. J. Melidou, A. Nohynek, H. Olmedo, C. Olsson, K. Pavlopoulou, I. Piechotta, V. Rubin, J. Schlaberg, J. Schmucker, C. Siemens, W. Stratil, J. Ucakar, V. Wichmann, O. Harder, T.
Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review
Adults Older adults Influenza Efficacy/effectiveness Safety
Rating:
High
2025 ∙ Kolsuz, S. Gullu, D. Karahan, K. D. Ergonul, O.
Risk factors and preventive role of vaccination in adult tetanus fatality: a systematic review of reported cases (1990-2024) and meta-analysis
Adults Older adults Tetanus Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Ugwu, C. L. J. Bragazzi, N. L. Wu, J. Kong, J. D. Asgary, A. Orbinski, J. Woldegerima, W. A.
Risk factors associated with human Mpox infection: A systematic review and meta-Analysis
All age groups Mpox Efficacy/effectiveness
Rating:
Low
2025 ∙ Kosmeri, C. Klapas, A. Evripidou, N. Kantza, E. Serbis, A. Siomou, E. Ladomenou, F.
Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis
Children Rotavirus Efficacy/effectiveness
Rating:
Critically low
Loading...